Wave Life Sciences
39 hedge funds and large institutions have $294M invested in Wave Life Sciences in 2016 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 4 closing their positions.
400% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 4
70% more funds holding
Funds holding: 23 → 39 (+16)
53% more capital invested
Capital invested by funds: $192M → $294M (+$102M)
50% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 6
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$5.92M |
| 2 |
PA
Perceptive Advisors
New York
|
+$5.4M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.98M |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.32M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$872K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
-$6.88M |
| 2 |
Jennison Associates
New York
|
-$5.12M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$2.22M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.75M |
| 5 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$1.72M |
WVE Hedge Fund Activity: Q2 2016 in Review
39 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q2 2016, worth a combined $294M — up 53% from $192M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new WVE positions and 4 closed out — a net gain of 16 holders — while 9 added to existing stakes and 6 trimmed.
The largest buyer was Eventide Asset Management, opening a new position worth an estimated $5.92M. The largest seller was Foresite Capital Management III, cutting an estimated $6.88M.
- 39 institutional investors held Wave Life Sciences (WVE) as of Q2 2016, up from 23 in Q1 2016.
- Funds reported $294M of Wave Life Sciences stock for Q2 2016, up 53% quarter-over-quarter.
- 20 funds opened new Wave Life Sciences positions in Q2 2016 and 4 closed out, a net change of +16 holders.
- The largest Wave Life Sciences buyer in Q2 2016 was Eventide Asset Management, an estimated $5.92M added.
- The largest Wave Life Sciences seller in Q2 2016 was Foresite Capital Management III, an estimated $6.88M sold.
Based on aggregated 13F filings for Q2 2016.